Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: Clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Wulf Johansson, Helle ^a   Johansson, Sofie Lock ^a   Schlosser, Anders ^a   Holm, Anne Trommelholt ^a   Rasmussen, Lars Melholt ^a,b   Mickley, Hans ^b   Diederichsen, Axel C P ^b   Munkholm, Henrik ^c   Svenstrup Poulsen, Tina ^b   Tornøe, Ida ^a   Nielsen, Vicki ^a   Marcussen, Niels ^b   Vestbo, Jørgen ^b,d   Sækmose, Susanne Gjørup ^a,e   Holmskov, Uffe ^a   Sorensen, Grith Lykke ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c LILLEBAELT HOSPITAL   (Denmark)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e NAESTVED HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBULIN 1; MESSENGER RNA; MICROFIBRILLAR ASSOCIATED PROTEIN 4; OSTEOPONTIN; OSTEOPROTEGERIN; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; DISEASE MARKER; ELASTIC FIBER; ELASTIC TISSUE; FEMALE; FETUS; HEART; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE; LUNG; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUSE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANIMALS; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; DEMOGRAPHY; ELASTIC TISSUE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGAN SPECIFICITY; OSTEOPONTIN; OSTEOPROTEGERIN; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 84892630535     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082243     Document Type: Article

References (44)

1. Thomsen T, Schlosser A, Holmskov U, Sorensen GL (2011) Ficolins and FIBCD1: soluble and membrane bound pattern recognition molecules with acetyl group selectivity. Mol Immunol 48: 369-381.
2. Farrell DH (2004) Pathophysiologic roles of the fibrinogen gamma chain. Curr Opin Hematol 11: 151-155.
3. LaFleur DW, Chiang J, Fagin JA, Schwartz SM, Shah PK, et al. (1997) Aortic smooth muscle cells interact with tenascin-C through its fibrinogen-like domain. J Biol Chem 272: 32798-32803.
4. Chan CW, Kay LS, Khadaroo RG, Chan MW, Lakatoo S, et al. (2003) Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol 170: 4036-4044.
5. Doolittle RF, McNamara K, Lin K (2012) Correlating structure and function during the evolution of fibrinogen-related domains. Protein Sci 21: 1808-1823.
6. Zhao Z, Lee CC, Jiralerspong S, Juyal RC, Lu F, et al. (1995) The gene for a human microfibril-associated glycoprotein is commonly deleted in Smith-Magenis syndrome patients. Hum Mol Genet 4: 589-597.
7. Ruoslahti E (1996) RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12: 697-715.
8. Schlosser A, Thomsen T, Shipley JM, Hein PW, Brasch F, et al. (2006) Microfibril-associated protein 4 binds to surfactant protein A (SP-A) and colocalizes with SP-A in the extracellular matrix of the lung. Scand J Immunol 64: 104-116.
9. Toyoshima T, Ishida T, Nishi N, Kobayashi R, Nakamura T, et al. (2008) Differential gene expression of 36-kDa microfibril-associated glycoprotein (MAGP-36/MFAP4) in rat organs. Cell Tissue Res 332: 271-278.
10. Kobayashi R, Mizutani A, Hidaka H (1994) Isolation and characterization of a 36-kDa microfibril-associated glycoprotein by the newly synthesized isoquinolinesulfonamide affinity chromatography. Biochem Biophys Res Commun 198: 1262-1266.
11. Toyoshima T, Yamashita K, Furuichi H, Shishibori T, Itano T, et al. (1999) Ultrastructural distribution of 36-kD microfibril-associated glycoprotein (MAGP-36) in human and bovine tissues. J Histochem Cytochem 47: 1049- 1056.
12. Kasamatsu S, Hachiya A, Fujimura T, Sriwiriyanont P, Haketa K, et al. (2011) Essential role of microfibrillar-associated protein 4 in human cutaneous homeostasis and in its photoprotection. Scientific Reports 1, 164; DOI:10.1038/srep00164 (2011).
13. Toyoshima T, Nishi N, Kusama H, Kobayashi R, Itano T (2005) 36-kDa microfibril-associated glycoprotein (MAGP-36) is an elastin-binding protein increased in chick aortae during development and growth. Exp Cell Res 307: 224-230.
14. Kielty CM, Sherratt MJ, Shuttleworth CA (2002) Elastic fibres. J Cell Sci 115: 2817-2828.
15. Hitz MP, Lemieux-Perreault LP, Marshall C, Feroz-Zada Y, Davies R, et al. (2012) Rare copy number variants contribute to congenital left-sided heart disease. PLoS Genet 8: e1002903.
16. Pilop C, Aregger F, Gorman RC, Brunisholz R, Gerrits B, et al. (2009) Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms. Circulation 120: 983-991.
17. Modrego J, Lopez-Farre AJ, Martinez-Lopez I, Muela M, Macaya C, et al. (2012) Expression of cytoskeleton and energetic metabolism-related proteins at human abdominal aortic aneurysm sites. J Vasc Surg 55: 1124-1133.
18. Abdul-Salam VB, Wharton J, Cupitt J, Berryman M, Edwards RJ, et al. (2010) Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension. Circulation 122: 2058-2067.
19. Molleken C, Sitek B, Henkel C, Poschmann G, Sipos B, et al. (2009) Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology 49: 1257-1266.
20. Libby P (2013) Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 368: 2004-2013.
21. Kuznetsova T, Herbots L, Lopez B, Jin Y, Richart T, et al. (2009) Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2: 105-112.
22. Sundstrom J, Vasan RS (2006) Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events. Curr Opin Lipidol 17: 45-53.
23. Zannad F, Pitt B (2009) Biomarkers of extracellular matrix turnover. Heart Fail Clin 5: 589-599.
24. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497.
25. Vinholt PJ, Overgaard M, Diederichsen AC, Mickley H, Poulsen TS, et al. (2013) An ELISA for the quantitation of von Willebrand Factor: Osteoprotegerin complexes in plasma. Thromb Res.
26. Saaby L, Poulsen TS, Hosbond S, Larsen TB, Pyndt Diederichsen AC, et al. (2013) Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 126: 789-797.
27. Diederichsen AC, Sand NP, Norgaard B, Lambrechtsen J, Jensen JM, et al. (2012) Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study. Eur J Prev Cardiol 19: 558-564.
28. Cangemi C, Skov V, Poulsen MK, Funder J, Twal WO, et al. (2011) Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin Chem 57: 1556-1565.
29. Olesen P, Ledet T, Rasmussen LM (2005) Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha. Diabetologia 48: 561-568.
30. Ueland T, Jemtland R, Godang K, Kjekshus J, Hognestad A, et al. (2004) Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol 44: 1970-1976.
31. Shaker OG, El-Shehaby A, Nabih M (2010) Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. Angiology 61: 756-762.
32. Suezawa C, Kusachi S, Murakami T, Toeda K, Hirohata S, et al. (2005) Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. J Lab Clin Med 145: 33-40.
33. Yanagisawa H, Davis EC, Starcher BC, Ouchi T, Yanagisawa M, et al. (2002) Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415: 168-171.
34. McLaughlin PJ, Chen Q, Horiguchi M, Starcher BC, Stanton JB, et al. (2006) Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice. Mol Cell Biol 26: 1700-1709.
35. (2011) Statistical Yearbook; Agerskov U, Bigaard MP, editors: Statistics Denmark. 1-525 p.
36. de la Cuesta F, Alvarez-Llamas G, Maroto AS, Donado A, Zubiri I, et al. (2011) A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. Mol Cell Proteomics 10: M110 003517.
37. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, Bjerkehagen B, Ohnstad HO, et al. (2006) Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res 66: 8984-8993.
38. Modrego J, Lopez-Farre AJ, Martinez-Lopez I, Muela M, Macaya C, et al. (2012) Expression of cytoskeleton and energetic metabolism-related proteins at human abdominal aortic aneurysm sites. J Vasc Surg.
39. Hirano E, Fujimoto N, Tajima S, Akiyama M, Ishibashi A, et al. (2002) Expression of 36-kDa microfibril-associated glycoprotein (MAGP-36) in human keratinocytes and its localization in skin. J Dermatol Sci 28: 60-67.
40. Proudfoot D, Shanahan CM (2001) Biology of calcification in vascular cells: intima versus media. Herz 26: 245-251.
41. Robert L, Robert A (1980) Elastin, elastase and arteriosclerosis. Front Matrix Biology 8: 130-173.
42. Robert L, Jacob MP, Frances C, Godeau G, Hornebeck W (1984) Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A review. Mech Ageing Dev 28: 155-166.
43. Kruger R, Schutte R, Huisman HW, Argraves WS, Rasmussen LM, et al. (2012) NT-proBNP is associated with fibulin-1 in Africans: the SAfrEIC study. Atherosclerosis 222: 216-221.
44. Dahl JS, Moller JE, Videbaek L, Poulsen MK, Rudbaek TR, et al. (2012) Plasma fibulin-1 is linked to restrictive filling of the left ventricle and to mortality in patients with aortic valve stenosis. J Am Heart Assoc 1: e003889.